Antitumour activity of Rhinacanthone against Dalton's ascitic lymphoma

dc.contributor.author	Thirumurugan, R.S.
dc.contributor.author	Kavimani, S.
dc.contributor.author	Srivastava, R.S.
dc.date.accessioned	2021-09-08T05:04:15Z
dc.date.available	2021-09-08T05:04:15Z
dc.date.issued	2000
dc.identifier.issn	09186158
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/1632
dc.description.abstract	The antitumour activity of Rhinacanthone (3,4-dihydro-3,3-dimethyl-2H-naphtho-[1,2-B] pyran-5,6-dione) has been evaluated against Dalton's ascitic lymphoma (DAL) in Swiss albino mice. A significant enhancement of mean survival time of tumour bearing mice and peritoneal cell count in normal mice was observed with respect to the control group. When these Rhinacanthone treated animals underwent i.p. inoculation with DAL cells, tumour cell growth was found to be inhibited. After 14 d of inoculation, Rhinacanthone was able to reverse the changes in the haemotological parameters, protein and packed cellular volume consequent to tumour inoculation.	en_US
dc.description.sponsorship	Biological and Pharmaceutical Bulletin	en_US
dc.language.iso	en	en_US
dc.publisher	Pharmaceutical Society of Japan	en_US
dc.relation.ispartofseries	Issue 12;Volume 23
dc.subject	Dalton's ascitic lymphoma;	en_US
dc.subject	Haemotological study;	en_US
dc.subject	Life span;	en_US
dc.subject	Rhinacanthus nasutus	en_US
dc.title	Antitumour activity of Rhinacanthone against Dalton's ascitic lymphoma	en_US
dc.type	Article	en_US